BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-03-13
• Last 15 days FTD volume: $0.39 M
• Last 3 months FTD volume: $1.28 M
• Last 12 months FTD volume: $6.08 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	$33.24 M	$0.27 B	🇺🇸 USA
GSK plc GSK	$21.92 M	$0.23 B	🇬🇧 UK
Sarepta Therapeutics SRPT	$4.54 M	$23.17 M	🇺🇸 USA
Repligen RGEN	$7.76 M	$22.99 M	🇺🇸 USA
Novavax NVAX	$16.56 M	$66.56 M	🇺🇸 USA
Celldex Therapeutics CLDX	$1.57 M	$11.79 M	🇺🇸 USA
NanoViricides NNVC	$0 M	$4.07 M	🇺🇸 USA
Cel-Sci CVM	N/A	$0.3 M	🇺🇸 USA
Emergent BioSolutions EBS	$0.37 M	$3.85 M	🇺🇸 USA